E. Sparrelid

1.5k total citations
31 papers, 1.2k citations indexed

About

E. Sparrelid is a scholar working on Epidemiology, Infectious Diseases and Hematology. According to data from OpenAlex, E. Sparrelid has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Infectious Diseases and 8 papers in Hematology. Recurrent topics in E. Sparrelid's work include Hematopoietic Stem Cell Transplantation (7 papers), Virus-based gene therapy research (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). E. Sparrelid is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Virus-based gene therapy research (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). E. Sparrelid collaborates with scholars based in Sweden, United States and Denmark. E. Sparrelid's co-authors include Per Ljungman, Jan Andersson, Olle Ringdén, Jonas Mattsson, Mats Remberger, Jacek Winiarski, U Skansén-Saphir, J Aschan, Olle Ringd n and B Lönnqvist and has published in prestigious journals such as Blood, Transplantation and Clinical & Experimental Immunology.

In The Last Decade

E. Sparrelid

30 papers receiving 1.1k citations

Peers

E. Sparrelid
Claire Rieux France
Donna Salzman United States
Faézeh Legrand France
C Ferry France
Liang Piu Koh Singapore
Pascale E. P. Dekkers Netherlands
Sanit Makonkawkeyoon Thailand
Mikio Ueda Japan
Karen Nelson United States
Juan Carlos García‐Ruiz Spain
Claire Rieux France
E. Sparrelid
Citations per year, relative to E. Sparrelid E. Sparrelid (= 1×) peers Claire Rieux

Countries citing papers authored by E. Sparrelid

Since Specialization
Citations

This map shows the geographic impact of E. Sparrelid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Sparrelid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Sparrelid more than expected).

Fields of papers citing papers by E. Sparrelid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Sparrelid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Sparrelid. The network helps show where E. Sparrelid may publish in the future.

Co-authorship network of co-authors of E. Sparrelid

This figure shows the co-authorship network connecting the top 25 collaborators of E. Sparrelid. A scholar is included among the top collaborators of E. Sparrelid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Sparrelid. E. Sparrelid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hasselgren, Kristina, Peter Nørgaard Larsen, E. Sparrelid, et al.. (2024). Long-term follow-up of patients with advanced colorectal liver metastasis: a survival analysis from the randomized controlled multicenter trial LIGRO. HPB. 26. S23–S23. 1 indexed citations
2.
Stoop, Thomas F., Poya Ghorbani, Erick J. Bergquist, et al.. (2021). Total pancreatectomy as an alternative to high-risk pancreatojejunostomy after pancreatoduodenectomy: a propensity score analysis on surgical outcome and quality of life. HPB. 23. S844–S844. 3 indexed citations
3.
Nordén, Rickard, Davide Valentini, Johan Westin, et al.. (2020). Hepatitis E virus is an infrequent but potentially serious infection in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplantation. 55(7). 1255–1263. 8 indexed citations
4.
Ljungman, Per, et al.. (2018). Norovirus causing severe gastrointestinal disease following allogeneic hematopoietic stem cell transplantation: A retrospective analysis. Transplant Infectious Disease. 20(2). e12847–e12847. 9 indexed citations
5.
Allard, Annika, et al.. (2015). Prolonged outbreak of adenovirus A31 in allogeneic stem cell transplant recipients. Transplant Infectious Disease. 17(6). 785–794. 15 indexed citations
6.
Kvist, Maria, et al.. (2014). Detecting Healthcare-Associated Infections in Electronic Health Records : Evaluation of Machine Learning and Preprocessing Techniques. 3–10. 7 indexed citations
7.
Färnert, Anna, Johan Ursing, Thomas Tolfvenstam, et al.. (2012). Artemether–lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania. Malaria Journal. 11(1). 176–176. 27 indexed citations
8.
Omar, Hamdy, H Hägglund, Katarina LeBlanc, et al.. (2009). Targeted monitoring of patients at high risk of post‐transplant lymphoproliferative disease by quantitative Epstein–Barr virus polymerase chain reaction. Transplant Infectious Disease. 11(5). 393–399. 59 indexed citations
9.
Avetisyan, Gayane, Jonas Mattsson, E. Sparrelid, & Per Ljungman. (2009). Respiratory Syncytial Virus Infection in Recipients of Allogeneic Stem-Cell Transplantation: A Retrospective Study of the Incidence, Clinical Features, and Outcome. Transplantation. 88(10). 1222–1226. 63 indexed citations
10.
Ihendyane, Nahla, E. Sparrelid, Bengt Wretlind, et al.. (2004). Viridans streptococcal septicaemia in neutropenic patients: role of proinflammatory cytokines. Bone Marrow Transplantation. 33(1). 79–85. 7 indexed citations
11.
Aschan, J, Ilona Lewensohn‐Fuchs, Stefan Carlens, et al.. (1998). RESULTS OF DIFFERENT STRATEGIES FOR REDUCING CYTOMEGALOVIRUS-ASSOCIATED MORTALITY IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS1. Transplantation. 66(10). 1330–1334. 131 indexed citations
12.
Hägglund, H, Olle Ringdén, Mats Remberger, et al.. (1998). Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow. Bone Marrow Transplantation. 22(2). 131–136. 30 indexed citations
13.
Ringdén, Olle, Mats Remberger, Jonas Mattsson, et al.. (1998). Transplantation with unrelated bone marrow in leukaemic patients above 40 years of age. Bone Marrow Transplantation. 21(1). 43–49. 26 indexed citations
14.
Sparrelid, E., H Hägglund, Mats Remberger, et al.. (1998). Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection. Bone Marrow Transplantation. 22(8). 795–800. 74 indexed citations
15.
Ringdén, Olle, Mats Remberger, Jonas Mattsson, et al.. (1997). Transplantation with unrelated bone marrow in leukemic patients above 40 years of age. Transplantation Proceedings. 29(7). 3145–3146. 1 indexed citations
16.
Sparrelid, E., Per Ljungman, J Aschan, et al.. (1997). Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplantation. 19(9). 905–908. 89 indexed citations
17.
Sparrelid, E., David Emanuel, Thomas E. Fehniger, & Jan Andersson. (1997). INTERSTITIAL PNEUMONITIS IN BONE MARROW TRANSPLANT RECIPIENTS IS ASSOCIATED WITH LOCAL PRODUCTION OF TH2-TYPE CYTOKINES AND LACK OF T CELL-MEDIATED CYTOTOXICITY1. Transplantation. 63(12). 1782–1789. 31 indexed citations
18.
Andersson, Jan, U Skansén-Saphir, & E. Sparrelid. (1996). Intravenous immune globulin affects cytokine production in T lymphocytes and monocytesjmacrophages. Clinical & Experimental Immunology. 104(Supplement_1). 10–20. 114 indexed citations
19.
Ljungman, Per, Jacob Andersson, & E. Sparrelid. (1995). [Infections following bone marrow transplantation].. PubMed. 110(12). 320–1. 2 indexed citations
20.
Ringdén, Olle, C. G. Groth, Anders Erikson, et al.. (1995). TEN YEARS' EXPERIENCE OF BONE MARROW TRANSPLANTATION FOR GAUCHER DISEASE. Transplantation. 59(6). 864–870. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire Rieux Breakdown of academic impact, for papers by Donna Salzman Breakdown of academic impact, for papers by Faézeh Legrand Breakdown of academic impact, for papers by C Ferry Breakdown of academic impact, for papers by Liang Piu Koh Breakdown of academic impact, for papers by Pascale E. P. Dekkers Breakdown of academic impact, for papers by Sanit Makonkawkeyoon Breakdown of academic impact, for papers by Mikio Ueda Breakdown of academic impact, for papers by Karen Nelson Breakdown of academic impact, for papers by Juan Carlos García‐Ruiz
Rankless by CCL
2026